Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A system for reporting quantitative antimicrobic susceptibility test results.

A L Barry

    American Journal of Clinical Pathology
    |November 1, 1979
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Something New-Nitric Acid a Remedy for Stings and Poisons.

    The Southern medical record·2022
    Same author

    Cefuroxime, an in vitro Comparison with Six Other Cephalosporins.

    Proceedings of the Royal Society of Medicine·2010
    Same author

    Ceftazidime, a pseudomonas-active cephalosporin: in-vitro antimicrobial activity evaluation including recommendations for disc diffusion susceptibility tests.

    The Journal of antimicrobial chemotherapy·2009
    Same author

    Precision and accuracy of fluconazole susceptibility testing by broth microdilution, Etest, and disk diffusion methods.

    Antimicrobial agents and chemotherapy·2002
    Same author

    Standardization of broth microdilution and disk diffusion susceptibility tests for Actinobacillus pleuropneumoniae and Haemophilus somnus: quality control standards for ceftiofur, enrofloxacin, florfenicol, gentamicin, penicillin, tetracycline, tilmicosin, and trimethoprim-sulfamethoxazole.

    Journal of clinical microbiology·2001
    Same author

    Evaluation of daptomycin susceptibility testing by Etest and the effect of different batches of media.

    The Journal of antimicrobial chemotherapy·2001

    This study introduces a novel laboratory reporting system for antimicrobial susceptibility testing. It communicates quantitative results to physicians, optimizing antibiotic use and indicating the degree of bacterial susceptibility.

    Area of Science:

    • Clinical Microbiology
    • Infectious Diseases
    • Pharmacology

    Background:

    • Effective communication of antimicrobial susceptibility testing (AST) results is crucial for appropriate antibiotic selection.
    • Current reporting methods may not always provide physicians with the optimal information for clinical decision-making.
    • Accurate interpretation of AST data can improve patient outcomes and combat antimicrobial resistance.

    Purpose of the Study:

    • To describe a new laboratory reporting system for quantitative antimicrobial susceptibility test results.
    • To enhance physician utilization of AST data for optimizing antibiotic therapy.
    • To provide a clear indication of the degree of antimicrobial susceptibility.

    Main Methods:

    • Development of a reporting system designed for laboratory-physician communication.

    Related Experiment Videos

  • Reporting of Minimal Inhibitory Concentrations (MICs) on a clinically relevant scale.
  • Integration of achievable concentration data to interpret susceptibility levels.

    • Main Results:

    • The system facilitates clearer communication of quantitative AST results.
    • Physicians receive MICs presented in a clinically actionable format.
    • The reporting scale aids in understanding the degree of microbial susceptibility to antibiotics.

    Conclusions:

    • The described reporting system optimizes the utilization of antimicrobial susceptibility test results.
    • Reporting MICs on a scale of clinically achievable concentrations improves the interpretation of susceptibility.
    • This approach supports informed antibiotic prescribing and stewardship efforts.